amphetamine sulfate

Generic: amphetamine sulfate

Labeler: wilshire pharmaceuticals, inc.
NDC Directory HUMAN PRESCRIPTION DRUG ANDA Inactive Finished

Drug Facts

Product Profile

Brand Name amphetamine sulfate
Generic Name amphetamine sulfate
Labeler wilshire pharmaceuticals, inc.
Dosage Form TABLET
Routes
ORAL
Active Ingredients

amphetamine sulfate 10 mg/1

Manufacturer
Wilshire Pharmaceuticals, Inc.

Identifiers & Regulatory

Product NDC 52536-059
Product ID 52536-059_87867bbf-4f82-42a0-9586-a9f530be1d2a
Product Type HUMAN PRESCRIPTION DRUG
Marketing Category ANDA
Application Number ANDA200166
DEA Schedule cii
Listing Expiration 2027-12-31
Marketing Start 2018-03-29

Pharmacologic Class

Classes
central nervous system stimulant [epc] central nervous system stimulation [pe]

Normalized Code Variants

Searchable formats for this product NDC code

Digits Only 52536059
Hyphenated Format 52536-059

Supplemental Identifiers

RxCUI
884655 1600695
UPC
0352536059039 0352536057035
UNII
6DPV8NK46S

Packaging Origin

Original Packager
true

Resolved Product View

Precedence rule: structured NDC data is preferred, falling back to linked label metadata when unavailable. Source tags show the origin of each value.

Resolved Identity

Brand Name amphetamine sulfate (source: ndc)
Generic Name amphetamine sulfate (source: ndc)
Application Number ANDA200166 (source: ndc)
Routes
ORAL
source: ndc

Resolved Composition

Strengths
  • 10 mg/1
source: ndc
Packaging
  • 30 TABLET in 1 BOTTLE (52536-059-03)
source: ndc

Packages (1)

Ingredients (1)

amphetamine sulfate (10 mg/1)

Linked Drug Pages (1)

Raw FDA Data

View complete raw FDA NDC JSON payload
{"route": ["ORAL"], "spl_id": "87867bbf-4f82-42a0-9586-a9f530be1d2a", "openfda": {"upc": ["0352536059039", "0352536057035"], "unii": ["6DPV8NK46S"], "rxcui": ["884655", "1600695"], "spl_set_id": ["91add2e3-8359-47dc-b79f-197d36b02819"], "manufacturer_name": ["Wilshire Pharmaceuticals, Inc."], "is_original_packager": [true]}, "finished": true, "packaging": [{"sample": false, "description": "30 TABLET in 1 BOTTLE (52536-059-03)", "package_ndc": "52536-059-03", "marketing_start_date": "20210107"}], "brand_name": "Amphetamine Sulfate", "product_id": "52536-059_87867bbf-4f82-42a0-9586-a9f530be1d2a", "dosage_form": "TABLET", "pharm_class": ["Central Nervous System Stimulant [EPC]", "Central Nervous System Stimulation [PE]"], "product_ndc": "52536-059", "dea_schedule": "CII", "generic_name": "Amphetamine Sulfate", "labeler_name": "Wilshire Pharmaceuticals, Inc.", "product_type": "HUMAN PRESCRIPTION DRUG", "brand_name_base": "Amphetamine Sulfate", "active_ingredients": [{"name": "AMPHETAMINE SULFATE", "strength": "10 mg/1"}], "application_number": "ANDA200166", "marketing_category": "ANDA", "marketing_start_date": "20180329", "listing_expiration_date": "20271231"}